FDA Determines Regulatory Review Period for TRICLIP Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for patent extension of medical device TRICLIP, following submissions to the US Patent and Trademark Office (USPTO).